Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
02/2010
02/02/2010US7655797 Intermediates for making 2,4-pyrimidinediamine compounds
02/02/2010US7655688 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
02/02/2010US7655666 Substituted 1H-quinazoline-2,4-diones useful as AMPA receptor ligands
02/02/2010US7655663 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes
02/02/2010US7655656 crystalline 6-[[(3S,4R)-3,4-dihydro-3-hydroxy-6-[(3-hydroxypheny)sulfonyl]-2,2,3-trimethyl-2H-1-benzopyran-4-yl]oxy]-2-methyl-3(2H)-pyridazinone; industrial scale
02/02/2010US7655649 Inhibitors of Akt activity
02/02/2010CA2541301C P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same
02/02/2010CA2333963C Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds
01/2010
01/28/2010WO2010011853A2 Beta-and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
01/28/2010WO2010011684A2 Prodrug and fluoregenic compositions and methods for using the same
01/28/2010WO2010011570A1 Adamantyl diamide derivatives and uses of same
01/28/2010WO2010011538A1 Amidophenoxyindazoles useful as inhibitors of c-met
01/28/2010WO2010010970A1 Coloring matter for optical information recording medium and optical information recording medium
01/28/2010WO2010010933A1 Heterocyclidene-n-(3,4-dihydro-2(1h)-quinazolin-5-yl) acetamide derivative
01/28/2010WO2010010058A1 Method of preparing anhydrous alfusozin hydrochloride
01/28/2010WO2009145357A8 Benzo [1, 4] diazepines substituted at the 1-position by a ring, for use as antidepressants
01/28/2010WO2008137816A8 Tricyclic compounds as matrix metalloproteinase inhibitors
01/28/2010US20100022778 Process for production of sulfinylbenzimidazole compounds or salts thereof
01/28/2010US20100022589 Pyridine-3-carboxamide compounds and their use for inhibiting 11-beta-hydroxysteroid dehydrogenase
01/28/2010US20100022547 Compounds and Methods for Treating Mammalian Gastrointestinal Parasitic Infections
01/28/2010US20100022543 Cycloalkylidene and heterocycloalkylidene inhibitor compounds
01/28/2010US20100022516 4,5-Disubstituted-2-aryl pyrimidines
01/28/2010US20100022484 4-Chromenonyl-1,4-dihydropyridines and their use
01/28/2010CA2731869A1 Beta-and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
01/28/2010CA2731773A1 Amidophenoxyindazoles useful as inhibitors of c-met
01/28/2010CA2728629A1 Adamantyl diamide derivatives and uses of same
01/27/2010EP2146967A2 Tetrahydroindole and tetrahydroindazole derivatives
01/27/2010EP2146957A1 Quaternary ammonium compounds useful as muscarinic receptor antagonists
01/27/2010EP2146779A1 Sulfonyl amide derivatives for the treatment of abnormal cell growth
01/27/2010EP2146753A2 18f fluoro-benzoyl labelled biological active compounds as diagnostic imaging agents as well as benzotriazol-1-yloxy-benzoyl , 2,5-dioxo-pyrrolidin-1-yloxy)benzoyl and trimethylammonio-benzoyl precursers thereof
01/27/2010EP2146715A1 Cgrp receptor antagonists with tertiary amide, sulfonamide, carbamate and urea end groups
01/27/2010EP2044051B1 Pyridine and pyrazine derivatives as mnk kinase inhibitors
01/27/2010EP1656353B1 Gabanergic modulators
01/27/2010EP1438298B1 Piperazine derivatives with ccr1 receptor antagonist activity
01/27/2010CN101636396A Process for the preparation of (r) -5- (2-aminoethyl) -1- (6, 8 -di fluorochroman- s -yl ) -1, 3-dihydroimidazole-2-thione
01/27/2010CN101633645A N3 alkylated benzimidazole derivatives as mek inhibitors
01/27/2010CN101633644A N3 alkylated benzimidazole derivatives as mek inhibitors
01/27/2010CN100586244C Compound, charge transporting material and organic electroluminescent element
01/27/2010CN100584891C Sulfoxides or sulfones grafted onto polymers
01/27/2010CN100584832C 2,4-di (phenylamino) pyrimidines useful in the treatment of proliferative disorders
01/27/2010CN100584830C Gabanergic modulators
01/26/2010US7652153 Caspase inhibitors and uses thereof
01/26/2010US7652141 Immunosuppressants, analgesics, antiinflammatory agents
01/26/2010US7652060 Small molecule rotamase enzyme inhibitors
01/26/2010US7652040 Aminosulfonyl substituted 4-(aminomethyl)-piperidine benzamides as 5HT4-antagonists
01/26/2010US7652020 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction
01/26/2010US7652011 Treating chronic neuropathic or inflammatory pain; [(1-methyl-1H-pyrrol-2-yl)methyl][[1-[(4-pyrazin-2-ylpiperazin-1-yl)acetyl]-4-[3-trifluoromethyl)phenyl]piperid-4-yl]methyl]amine
01/26/2010US7652010 Azabicyclic aryl derivatives and their medical use
01/26/2010US7652006 Substituted 1(2H)-phthalazinones and pharmaceutical compositions thereof
01/26/2010US7651978 Selective herbicides based on a substituted phenylsulphonylaminocarbonyl-triazolinone
01/26/2010CA2481012C Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
01/26/2010CA2470064C Triazolo-quinolin derivatives useful as adenosine receptor ligands
01/21/2010WO2010009290A1 Alpha7 nicotinic acetylcholine receptor inhibitors
01/21/2010WO2010009069A1 Chromene modulators of chemokine receptor activity
01/21/2010WO2010008081A1 Azo compound, azo pigment, pigment dispersion, color composition, inkjet recording ink, color composition for color filter, color filter, and method for preparing color composition for color filter
01/21/2010WO2010007972A1 Novel indole derivative having carbamoyl group, ureide group and substituted oxy group
01/21/2010WO2010007800A1 Novel uracil compound having amide structure and salt thereof
01/21/2010WO2010007756A1 Pyridine derivative having ttk inhibition activity
01/21/2010WO2010007382A1 Benzazepine derivatives and their use as hstamine h3 antagonists
01/21/2010WO2010006938A1 Novel heterocyclyl compounds for treatment of cardiovascular disease
01/21/2010WO2010006755A2 A compound for imaging cell death
01/21/2010WO2010006350A1 Melamine epoxides
01/21/2010WO2009125430A8 Improved process for producing darifenacin
01/21/2010WO2008156092A8 Azolylmethylidenehydrazine derivative and use thereof
01/21/2010US20100016380 TNF-alpha production inhibitors
01/21/2010US20100016343 Alpha7 nicotinic acetylcholine receptor inhibitors
01/21/2010US20100016332 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
01/21/2010US20100016320 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors
01/21/2010US20100016308 Tetrahydroindole Derivatives for Treatment of Alzheimer's Disease
01/21/2010US20100016285 Heterocyclidene-n-(aryl) acetamide derivative
01/21/2010US20100016252 Mannich Base N-Oxide Drugs
01/21/2010US20100016177 Templated molecules and methods for using such molecules
01/21/2010US20100016154 Imaging system
01/21/2010US20100015130 Disc-1 pathway activators in the control of neurogenesis
01/21/2010US20100015063 Benzodiazepine Derivatives and Pharmaceutical Compositions Containing Them
01/21/2010CA2731196A1 Benzazepine derivatives and their use as hstamine h3 antagonists
01/21/2010CA2731053A1 A compound for imaging cell death
01/21/2010CA2730281A1 Novel indole derivative having, carbamoyl group, ureido group and substituted oxy group
01/21/2010CA2730056A1 Novel heterocyclyl compounds for treatment of cardiovascular disease
01/21/2010CA2729606A1 Alpha7 nicotinic acetylcholine receptor inhibitors
01/20/2010EP2145886A1 Twelve-membered cyclomacrolactam derivative
01/20/2010EP2145622A1 Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors
01/20/2010EP2144898A2 Heterocyclic hydrazide compound and pesticidal use of the same
01/20/2010EP2144893A2 Tricyclic compounds as matrix metalloproteinase inhibitors
01/20/2010EP2144885A1 Imidazolidine carboxamide derivatives as lipase and phospholipase inhibitors
01/20/2010EP2144879A2 Pyridonecarboxamides crop protection agents containing the same method for production and use thereof
01/20/2010EP1828148B1 Triazole substituted aminobenzophenone compounds
01/20/2010EP1654247B1 Alkynyl aryl carboxamides
01/20/2010EP1458679B1 Pyrrolidine derivatives as prostaglandin modulators
01/20/2010EP1202961B1 Arylsulfonamido-substituted hydroxamic acid derivatives
01/20/2010EP1077994B1 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same
01/20/2010CN101628888A Inhibitors of cytosolic phospholipase A2
01/20/2010CN100582103C 4-(2-furoyl)aminopiperidine compound useful as therapeutic agent for itching
01/19/2010US7649085 Saquinavir conjugates and antibodies useful in immunoassay
01/19/2010US7649011 Inhibitors of human tumor-expressed CCXCKR2
01/19/2010US7649002 (3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists
01/19/2010US7649001 Fused benzene derivative and use
01/19/2010US7648971 Thrombopoietin mimetics
01/19/2010US7648959 Methods and compositions for the treatment of diseases of the eye
01/19/2010US7648738 for photopolymerization; photography, relief imaging; color filters